ASX - By Stock
|
IMU |
Re:
Ann: Imugene and RenovoRx CF33 Virotherapy Delivery Collaboration
|
|
thetooch
|
168 |
76K |
0 |
20/07/23 |
20/07/23 |
ASX - By Stock
|
168
|
76K
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene and RenovoRx CF33 Virotherapy Delivery Collaboration
|
|
thetooch
|
168 |
76K |
6 |
20/07/23 |
20/07/23 |
ASX - By Stock
|
168
|
76K
|
6
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene and RenovoRx CF33 Virotherapy Delivery Collaboration
|
|
thetooch
|
168 |
76K |
40 |
20/07/23 |
20/07/23 |
ASX - By Stock
|
168
|
76K
|
40
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene and RenovoRx CF33 Virotherapy Delivery Collaboration
|
|
thetooch
|
168 |
76K |
24 |
20/07/23 |
20/07/23 |
ASX - By Stock
|
168
|
76K
|
24
|
|
ASX - By Stock
|
IMU |
Re:
Ann: New Dose Escalation in Phase I Clinical Trial of CHECKvacc
|
|
thetooch
|
96 |
44K |
15 |
07/07/23 |
07/07/23 |
ASX - By Stock
|
96
|
44K
|
15
|
|
ASX - By Stock
|
IMU Biotech |
Re:
Bioshares Conference 24th July - is anyone going?
|
|
thetooch
|
3 |
1.4K |
8 |
06/07/23 |
06/07/23 |
ASX - By Stock
|
3
|
1.4K
|
8
|
|
ASX - By Stock
|
IMU Biotech |
Re:
Bioshares Conference 24th July - is anyone going?
|
|
thetooch
|
3 |
1.4K |
6 |
06/07/23 |
06/07/23 |
ASX - By Stock
|
3
|
1.4K
|
6
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Change of Director's Interest Notice
|
|
thetooch
|
222 |
88K |
3 |
02/07/23 |
02/07/23 |
ASX - By Stock
|
222
|
88K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Change of Director's Interest Notice
|
|
thetooch
|
222 |
88K |
2 |
02/07/23 |
02/07/23 |
ASX - By Stock
|
222
|
88K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Change of Director's Interest Notice
|
|
thetooch
|
222 |
88K |
35 |
30/06/23 |
30/06/23 |
ASX - By Stock
|
222
|
88K
|
35
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
thetooch
|
14K |
6.8M |
2 |
29/06/23 |
29/06/23 |
ASX - By Stock
|
14K
|
6.8M
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
thetooch
|
14K |
6.8M |
1 |
29/06/23 |
29/06/23 |
ASX - By Stock
|
14K
|
6.8M
|
1
|
|
ASX - By Stock
|
MAY |
Re:
Ann: Block 9, Cuba Commencement of drilling of Alameda 2
|
|
thetooch
|
334 |
131K |
22 |
20/06/23 |
20/06/23 |
ASX - By Stock
|
334
|
131K
|
22
|
|
ASX - By Stock
|
IMU |
Re:
Why IMU is a multi multi bagger
|
|
thetooch
|
25K |
12M |
34 |
31/05/23 |
31/05/23 |
ASX - By Stock
|
25K
|
12M
|
34
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Investor Webinar - FDA IND Clearance for onCARlytics
|
|
thetooch
|
67 |
31K |
9 |
22/05/23 |
22/05/23 |
ASX - By Stock
|
67
|
31K
|
9
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Investor Webinar - FDA IND Clearance for onCARlytics
|
|
thetooch
|
67 |
31K |
2 |
22/05/23 |
22/05/23 |
ASX - By Stock
|
67
|
31K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Investor Webinar - FDA IND Clearance for onCARlytics
|
|
thetooch
|
67 |
31K |
0 |
22/05/23 |
22/05/23 |
ASX - By Stock
|
67
|
31K
|
0
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene Investor Webinar - FDA IND Clearance for onCARlytics
|
|
thetooch
|
67 |
31K |
18 |
22/05/23 |
22/05/23 |
ASX - By Stock
|
67
|
31K
|
18
|
|
ASX - By Stock
|
IMU |
Re:
Ann: FDA clears Imugene IND for onCARlytics first-in-class study
|
|
thetooch
|
148 |
66K |
11 |
19/05/23 |
19/05/23 |
ASX - By Stock
|
148
|
66K
|
11
|
|
ASX - By Stock
|
IMU |
Re:
Ann: FDA clears Imugene IND for onCARlytics first-in-class study
|
|
thetooch
|
148 |
66K |
3 |
19/05/23 |
19/05/23 |
ASX - By Stock
|
148
|
66K
|
3
|
|
ASX - By Stock
|
IMU |
Re:
Ann: FDA clears Imugene IND for onCARlytics first-in-class study
|
|
thetooch
|
148 |
66K |
7 |
19/05/23 |
19/05/23 |
ASX - By Stock
|
148
|
66K
|
7
|
|
ASX - By Stock
|
IMU |
Re:
Ann: FDA clears Imugene IND for onCARlytics first-in-class study
|
|
thetooch
|
148 |
66K |
2 |
19/05/23 |
19/05/23 |
ASX - By Stock
|
148
|
66K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: FDA clears Imugene IND for onCARlytics first-in-class study
|
|
thetooch
|
148 |
66K |
1 |
19/05/23 |
19/05/23 |
ASX - By Stock
|
148
|
66K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Ann: FDA clears Imugene IND for onCARlytics first-in-class study
|
|
thetooch
|
148 |
66K |
2 |
19/05/23 |
19/05/23 |
ASX - By Stock
|
148
|
66K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: FDA clears Imugene IND for onCARlytics first-in-class study
|
|
thetooch
|
148 |
66K |
56 |
19/05/23 |
19/05/23 |
ASX - By Stock
|
148
|
66K
|
56
|
|
ASX - By Stock
|
MAY |
Re:
May Chart
|
|
thetooch
|
12K |
4.2M |
3 |
19/05/23 |
19/05/23 |
ASX - By Stock
|
12K
|
4.2M
|
3
|
|
ASX - By Stock
|
MAY |
Re:
May Chart
|
|
thetooch
|
12K |
4.2M |
3 |
19/05/23 |
19/05/23 |
ASX - By Stock
|
12K
|
4.2M
|
3
|
|
ASX - By Stock
|
MAY |
Re:
May Chart
|
|
thetooch
|
12K |
4.2M |
5 |
18/05/23 |
18/05/23 |
ASX - By Stock
|
12K
|
4.2M
|
5
|
|
ASX - By Stock
|
MAY |
Re:
Strong Open
|
|
thetooch
|
67 |
19K |
7 |
09/05/23 |
09/05/23 |
ASX - By Stock
|
67
|
19K
|
7
|
|
ASX - By Stock
|
MAY |
Re:
Strong Open
|
|
thetooch
|
67 |
19K |
12 |
09/05/23 |
09/05/23 |
ASX - By Stock
|
67
|
19K
|
12
|
|
ASX - By Stock
|
IMU Medicine |
Re:
Why cancer testing works on mice but not on human
|
|
thetooch
|
45 |
74K |
3 |
31/03/23 |
31/03/23 |
ASX - By Stock
|
45
|
74K
|
3
|
|
ASX - By Stock
|
IMU Medicine |
Re:
Why cancer testing works on mice but not on human
|
|
thetooch
|
45 |
74K |
48 |
31/03/23 |
31/03/23 |
ASX - By Stock
|
45
|
74K
|
48
|
|
ASX - By Stock
|
IMU Biotech |
Re:
The CF33, Vaxinia and Oncarlytics Deal
|
|
thetooch
|
1.0K |
646K |
32 |
30/03/23 |
30/03/23 |
ASX - By Stock
|
1.0K
|
646K
|
32
|
|
ASX - By Stock
|
MAY |
Re:
Ann: Cuba, Block 9 PSC Update on Alameda 2 appraisal well
|
|
thetooch
|
573 |
146K |
2 |
16/02/23 |
16/02/23 |
ASX - By Stock
|
573
|
146K
|
2
|
|
ASX - By Stock
|
MAY |
Re:
Ann: Cuba, Block 9 PSC Update on Alameda 2 appraisal well
|
|
thetooch
|
573 |
146K |
7 |
16/02/23 |
16/02/23 |
ASX - By Stock
|
573
|
146K
|
7
|
|
ASX - By Stock
|
MAY |
Re:
Ann: Cuba, Block 9 PSC Update on Alameda 2 appraisal well
|
|
thetooch
|
573 |
146K |
22 |
16/02/23 |
16/02/23 |
ASX - By Stock
|
573
|
146K
|
22
|
|
ASX - By Stock
|
IMU |
Re:
AROVELLA AND IMUGENE COLLABORATION ADVANCES TO NEXT PHASE OF TESTING
|
|
thetooch
|
16 |
6.3K |
16 |
10/02/23 |
10/02/23 |
ASX - By Stock
|
16
|
6.3K
|
16
|
|
ASX - By Stock
|
IMU |
Re:
AROVELLA AND IMUGENE COLLABORATION ADVANCES TO NEXT PHASE OF TESTING
|
|
thetooch
|
16 |
6.3K |
13 |
10/02/23 |
10/02/23 |
ASX - By Stock
|
16
|
6.3K
|
13
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
thetooch
|
14K |
6.8M |
30 |
08/02/23 |
08/02/23 |
ASX - By Stock
|
14K
|
6.8M
|
30
|
|
ASX - By Stock
|
MAY |
Re:
TA only
|
|
thetooch
|
2.5K |
704K |
2 |
12/01/23 |
12/01/23 |
ASX - By Stock
|
2.5K
|
704K
|
2
|
|
ASX - By Stock
|
MAY |
Re:
Pending New Substantial Holder notice ??
|
|
thetooch
|
43 |
18K |
0 |
16/12/22 |
16/12/22 |
ASX - By Stock
|
43
|
18K
|
0
|
|
ASX - By Stock
|
MAY |
Re:
Pending New Substantial Holder notice ??
|
|
thetooch
|
43 |
18K |
6 |
16/12/22 |
16/12/22 |
ASX - By Stock
|
43
|
18K
|
6
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene to Present at J.P. Morgan Healthcare Conference
|
|
thetooch
|
187 |
88K |
19 |
12/12/22 |
12/12/22 |
ASX - By Stock
|
187
|
88K
|
19
|
|
ASX - By Stock
|
MAY |
Re:
Ann: Notice of Annual General Meeting/Proxy Form
|
|
thetooch
|
65 |
22K |
1 |
22/11/22 |
22/11/22 |
ASX - By Stock
|
65
|
22K
|
1
|
|
ASX - By Stock
|
IMU |
Re:
Ann: AGM Presentation
|
|
thetooch
|
103 |
47K |
19 |
17/11/22 |
17/11/22 |
ASX - By Stock
|
103
|
47K
|
19
|
|
ASX - By Stock
|
IMU |
Re:
Ann: AGM Presentation
|
|
thetooch
|
103 |
47K |
1 |
17/11/22 |
17/11/22 |
ASX - By Stock
|
103
|
47K
|
1
|
|
ASX - By Stock
|
MAY |
Re:
Ann: Appraisal Program for Block 9, Cuba
|
|
thetooch
|
340 |
123K |
9 |
15/11/22 |
15/11/22 |
ASX - By Stock
|
340
|
123K
|
9
|
|
ASX - By Stock
|
IMU |
Re:
Media Thread
|
|
thetooch
|
14K |
6.8M |
13 |
11/11/22 |
11/11/22 |
ASX - By Stock
|
14K
|
6.8M
|
13
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Change of Director's Interest Notice - JE & CW
|
|
thetooch
|
75 |
26K |
2 |
09/11/22 |
09/11/22 |
ASX - By Stock
|
75
|
26K
|
2
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Change of Director's Interest Notice - JE & CW
|
|
thetooch
|
75 |
26K |
6 |
09/11/22 |
09/11/22 |
ASX - By Stock
|
75
|
26K
|
6
|
|